REFERENCES
- A. Albert, R. Goldrace, and J. Philips. (1948). The strength of heterocyclic bases. J. Chem. Soc. 70:2240–2249.
- A. Brändström, N. Bergman, and I. Grundevik. (1989). Chemical reactions of omeprazole and omeprazole analogues. III. Protolytic behaviour of compounds in the omeprazole system. Acta Chem. Scand. 43:569–576.
- P.M. Hellström, and S. Vitols. (2004). The choice of proton pump inhibitor: Does it matter?. Basic Clin. Pharmacol. Toxicol. 94:106–111.
- A. Kristl, and F. Vrecer. (2000). Preformulation investigation of the novel proton pump inhibitor lansoprazole. Drug Dev. Ind. Pharm. 26:781–783.
- Marvin® (ChemAxon, Hungary), http://www.chemaxon.com/demosite/marvin/index.html.
- pKalc Pallas (1995). Hungary: CompuDrug Chemistry Ltd.
- J. M. Shin, Y. M. Cho, and G. Sachs. (2004). Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J. Am. Chem. Soc. 126:7800–7811.
- VCCLAB, Virtual Computational Chemistry Laboratoryhttp://www.vcclaborg.2005.
- R. Yang, S. G. Schulman, and P. J. Zavala. (2003). Acid-base chemistry of omeprazole in aqueous solutions. Anal. Chim. Acta 481:155–164.